清除衰老细胞可促进肺动脉高压的发展与进展
研究探讨衰老细胞在肺动脉高压中的作用。在患者和多种动物模型中,清除衰老细胞(通过自杀基因、衰老细胞清除药物ABT263和FOXO4-DRI)会加重肺动脉高压血流动力学异常和血管重塑,并导致肺内皮细胞丢失。提示衰老细胞清除策略可能对肺血管产生不良影响。
要点
- 肺动脉高压患者肺组织衰老标志物p16、p21及DNA损伤标志物γ-H2AX升高。
- 在多种小鼠模型中,清除衰老细胞会加重右心室收缩压和血管重塑。
- 衰老细胞清除药物ABT263短期改善但长期加重 monocrotaline 大鼠肺动脉高压。
核心结论
- 清除衰老肺内皮细胞可能恶化肺动脉高压血流动力学,需警惕抗衰老策略对肺血管的潜在影响。
研究设计与样本
- 研究纳入肺动脉高压患者肺组织与多种小鼠及大鼠肺动脉高压模型,采用衰老标志物检测、 luminescence 成像监测p16激活,并通过自杀基因、ABT263、FOXO4-DRI及p16失活清除或抑制衰老细胞。
主要发现
- 肺动脉高压患者较对照肺组织p16、p21和γ-H2AX蛋白水平升高,血管细胞共表达p16、γ-H2AX和53BP1。
- 缺氧增加p16LUC/+小鼠胸部生物发光信号,野生型小鼠缺氧后肺衰老及DNA损伤标志物、SASP组分及肺内皮细胞p16染色增加。
- 通过自杀基因或ABT263清除衰老细胞增加右心室收缩压和肥厚指数、加重血管重塑并显著减少肺内皮细胞。
- 老年p16LUC/LUC小鼠、Sugen或缺氧+Sugen暴露野生型小鼠及SM22-5-HTT+小鼠给予ABT263或FOXO4-DRI后出现肺血流动力学改变和肺内皮细胞丢失。
- ABT263处理monocrotaline大鼠1周轻度减轻肺动脉高压严重程度,但3周时加重并伴肺内皮细胞丢失。
临床怎么用
- 临床考虑使用衰老细胞清除药物时,需评估其对肺血管和肺动脉高压风险的潜在不良影响。
局限性
- 研究基于动物模型和患者组织观察,衰老细胞清除策略的临床转化需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Senescent cells (SCs) are involved in proliferative disorders, but their role in pulmonary hypertension remains undefined. We investigated SCs in patients with pulmonary arterial hypertension and the role of SCs in animal pulmonary hypertension models. METHODS: We investigated senescence (p16, p21) and DNA damage (γ-H2AX, 53BP1) markers in patients with pulmonary arterial hypertension and murine models. We monitored p16 activation by luminescence imaging in p16-luciferase (p16LUC/+) knock-in mice. SC clearance was obtained by a suicide gene (p16 promoter-driven killer gene construct in p16-ATTAC mice), senolytic drugs (ABT263 and cell-permeable FOXO4-p53 interfering peptide [FOXO4-DRI]), and p16 inactivation in p16LUC/LUC mice. We investigated pulmonary hypertension in mice exposed to normoxia, chronic hypoxia, or hypoxia+Sugen, mice overexpressing the serotonin transporter (SM22-5-HTT+), and rats given monocrotaline. RESULTS: Patients with pulmonary arterial hypertension compared with controls exhibited high lung p16, p21, and γ-H2AX protein levels, with abundant vascular cells costained for p16, γ-H2AX, and 53BP1. Hypoxia increased thoracic bioluminescence in p16LUC/+ mice. In wild-type mice, hypoxia increased lung levels of senescence and DNA-damage markers, senescence-associated secretory phenotype components, and p16 staining of pulmonary endothelial cells (P-ECs, 30% of lung SCs in normoxia), and pulmonary artery smooth muscle cells. SC elimination by suicide gene or ABT263 increased the right ventricular systolic pressure and hypertrophy index, increased vessel remodeling (higher dividing proliferating cell nuclear antigen-stained vascular cell counts during both normoxia and hypoxia), and markedly decreased lung P-ECs. Pulmonary hemodynamic alterations and lung P-EC loss occurred in older p16LUC/LUC mice, wild-type mice exposed to Sugen or hypoxia+Sugen, and SM22-5-HTT+ mice given either ABT263 or FOXO4-DRI, compared with relevant controls. The severity of monocrotaline-induced pulmonary hypertension in rats was decreased slightly by ABT263 for 1 week but was aggravated at 3 weeks, with loss of P-ECs. CONCLUSIONS: Elimination of senescent P-ECs by senolytic interventions may worsen pulmonary hemodynamics. These results invite consideration of the potential impact on pulmonary vessels of strategies aimed at controlling cell senescence in various contexts.
引用
- Born E, Lipskaia L, Breau M, et al. Eliminating Senescent Cells Can Promote Pulmonary Hypertension Development and Progression. Circulation. 2022. PMID: 36515093. doi:10.1161/CIRCULATIONAHA.122.058794
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。